Skip to content

Elanco Animal Health Inc. ELAN Liability for sale of future revenue

Liability for sale of future revenue at other companies

Arrowhead Research logo
Arrowhead ResearchARWR
$383.83M+9.0%
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$557.77M+4.0%
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$551.35M+1.7%
Cytokinetics logo
CytokineticsCYTK
$539.11M+13.2%
Nuvalent, Inc. logo
Nuvalent, Inc.NUVL
$75.73M+291%
Lattice Semiconductor logo
Lattice SemiconductorLSCC
$0-100%

Other financials

Income statement

See full
Revenue$1.4B+14.9%
Gross profit$785.0M+14.8%
Net income$57.0M-14.9%
EPS (diluted)$0.11-15.4%

Balance sheet

See full
Cash & equivalents$428.0M-12.1%
Total debt$4.3B-1.7%
Total equity$6.5B+2.3%
Total assets$13.2B+2.2%

Cash flow

See full
Operating cash flow$13.0M+425%
CapEx$51.0M-21.5%
Free cash flow-$38.0M+44.9%

Valuation

See full
Market cap$12.1B+128%
Enterprise value$15.99B+73.1%
P/S2.5×+1.3×

Profitability

See full
Gross margin55.1%+0.2pp
Net margin-4.9%-13.6pp
FCF margin6.4%-1.4pp

Returns & leverage

See full
Return on equity-3.8%-9.9pp
Debt / equity0.7×0.0×
Current ratio2.2×-0.6×

Where this comes from

Reported directly by Elanco Animal Health Inc. in its filing.

Tagged under the XBRL concept elan:SaleOfFutureRevenueLiabilityNoncurrent.

The official record: Elanco Animal Health Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Elanco Animal Health Inc.'s liability for sale of future revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Elanco Animal Health Inc.'s liability for sale of future revenue?
Elanco Animal Health Inc. (ELAN) reported liability for sale of future revenue of $309M in Q1 2026.
What does liability for sale of future revenue mean?
A long-term obligation to share future revenue in exchange for upfront cash.
How do you interpret liability for sale of future revenue?
An increase indicates the company has monetized future revenue to raise capital, which may reduce future cash flow availability.
How does liability for sale of future revenue compare across companies?
Specific to companies with high-value intellectual property or long-term product revenue streams.